Next-generation liquid biopsy diagnostics.
Listen to Dr Meysam Keshavaraz talking about ExoNostic at The London Cancer District. ExoNostic is developing next-generation liquid biopsy diagnostics that enable earlier and more accessible disease detection. Their platform applies holistic molecular analysis to small biological samples, generating detailed diagnostic insights that support early cancer detection, treatment monitoring and wider biomarker discovery.
